Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital

Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital

Aim: The aim of this study is to determine the incidence of T790M mutations after progression on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) and median duration on TKI before progression on TKI. Methods: Records of Rajiv Gandhi Cancer Institute and Research Centre, of pa...

Full description

Bibliographic Details
Main Authors: Venkata Pradeep Babu Koyyala, Ullas Batra, Parveen Jain, Mansi Sharma, Pankaj Goyal, Pavani Medisetty, Ankush Jajodia, Udip Dilip Maheshwari
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Lung India
Subjects:
Epidermal growth factor receptor mutation
nonsmall cell lung cancer
osimertinib
T790M mutation
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2018;volume=35;issue=5;spage=390;epage=394;aulast=Babu

Similar Items

Similar Items